HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio.

Abstract
The chimeric monoclonal antibody U36 (cMAb U36) recognizes the CD44v6 antigen. Its potential as a radioimmunotargeting agent, as well as its safety, has been shown in previous studies in head and neck cancer patients. However, intact MAbs have long circulation time in the blood and tumor targeting may also be hampered due to the slow and incomplete diffusion into solid tumors. In comparison, smaller monovalent Fab' and divalent F(ab')2 fragments are expected to exhibit shorter circulating half-lives, better tumor penetration and are thus more likely to yield better imaging results. In this study, novel F(ab')2 and Fab' fragments from cMAb U36 were radiolabeled with 125I and the characteristics of the conjugates in vitro were examined. The biodistribution of the conjugates were then evaluated in nude mice bearing CD44v6-expressing xenograft tumors. Furthermore, the penetration depth and distribution in tumor tissue was assessed by autoradiography in selected tumor samples. The in vitro experiments showed that the conjugates were stable and had intact affinity to CD44v6. The biodistribution study demonstrated superior tumor-to-blood ratio for the novel cMAb U36 fragment 125I-F(ab')2 compared with both the intact MAb and the monovalent fragment form. Autoradiography also revealed better tumor penetration for 125I-F(ab')2. This study demonstrates that the use of antibody fragments may improve radioimmunotargeting and possibly improve the management of head and neck malignancies.
AuthorsK Sandström, A K Haylock, D Spiegelberg, F Qvarnström, K Wester, M Nestor
JournalInternational journal of oncology (Int J Oncol) Vol. 40 Issue 5 Pg. 1525-32 (May 2012) ISSN: 1791-2423 [Electronic] Greece
PMID22307465 (Publication Type: Journal Article)
Chemical References
  • (124)I-cMAb U36
  • Antibodies, Monoclonal
  • CD44v6 antigen
  • Hyaluronan Receptors
  • Immunoglobulin Fab Fragments
  • Iodine Radioisotopes
  • Radiopharmaceuticals
Topics
  • Animals
  • Antibodies, Monoclonal (administration & dosage, blood, pharmacokinetics)
  • Autoradiography
  • Carcinoma, Squamous Cell (diagnostic imaging, immunology, metabolism)
  • Cell Line, Tumor
  • Female
  • Half-Life
  • Head and Neck Neoplasms (diagnostic imaging, immunology, metabolism)
  • Humans
  • Hyaluronan Receptors (immunology)
  • Immunoglobulin Fab Fragments (administration & dosage, blood, metabolism)
  • Immunohistochemistry
  • Injections, Intravenous
  • Iodine Radioisotopes
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Transplantation
  • Radioimmunodetection (methods)
  • Radiopharmaceuticals (administration & dosage, blood, pharmacokinetics)
  • Tissue Distribution
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: